These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19816595)

  • 41. Cellular events mediated by lipopolysaccharide-stimulated toll-like receptor 4. MD-2 is required for activation of mitogen-activated protein kinases and Elk-1.
    Yang H; Young DW; Gusovsky F; Chow JC
    J Biol Chem; 2000 Jul; 275(27):20861-6. PubMed ID: 10877845
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of MD-2 in TLR2- and TLR4-mediated recognition of Gram-negative and Gram-positive bacteria and activation of chemokine genes.
    Dziarski R; Gupta D
    J Endotoxin Res; 2000; 6(5):401-5. PubMed ID: 11521063
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel TLR4-binding peptide that inhibits LPS-induced activation of NF-kappaB and in vivo toxicity.
    Sugiyama K; Muroi M; Tanamoto K
    Eur J Pharmacol; 2008 Oct; 594(1-3):152-6. PubMed ID: 18700140
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Toll-like receptor 4 region Glu24-Pro34 is critical for interaction with MD-2.
    Nishitani C; Mitsuzawa H; Hyakushima N; Sano H; Matsushima N; Kuroki Y
    Biochem Biophys Res Commun; 2005 Mar; 328(2):586-90. PubMed ID: 15694388
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lipopolysaccharide-trap-Fc, a multifunctional agent to battle gram-negative bacteria.
    Gross P; Brandl K; Dierkes C; Schölmerich J; Salzberger B; Glück T; Falk W
    Infect Immun; 2009 Jul; 77(7):2925-31. PubMed ID: 19433546
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase.
    Rhee SH; Hwang D
    J Biol Chem; 2000 Nov; 275(44):34035-40. PubMed ID: 10952994
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activation of Toll-like receptors by Burkholderia pseudomallei.
    West TE; Ernst RK; Jansson-Hutson MJ; Skerrett SJ
    BMC Immunol; 2008 Aug; 9():46. PubMed ID: 18691413
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide.
    Abreu MT; Vora P; Faure E; Thomas LS; Arnold ET; Arditi M
    J Immunol; 2001 Aug; 167(3):1609-16. PubMed ID: 11466383
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Computational Approaches to Toll-Like Receptor 4 Modulation.
    Billod JM; Lacetera A; Guzmán-Caldentey J; Martín-Santamaría S
    Molecules; 2016 Jul; 21(8):. PubMed ID: 27483231
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Essential roles of hydrophobic residues in both MD-2 and toll-like receptor 4 in activation by endotoxin.
    Resman N; Vasl J; Oblak A; Pristovsek P; Gioannini TL; Weiss JP; Jerala R
    J Biol Chem; 2009 May; 284(22):15052-60. PubMed ID: 19321453
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatic preconditioning using lipopolysaccharide: association with specific negative regulators of the Toll-like receptor 4 signaling pathway.
    Sano T; Izuishi K; Hossain MA; Inoue T; Kakinoki K; Hagiike M; Okano K; Masaki T; Suzuki Y
    Transplantation; 2011 May; 91(10):1082-9. PubMed ID: 21403587
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Soluble MD-2 activity in plasma from patients with severe sepsis and septic shock.
    Pugin J; Stern-Voeffray S; Daubeuf B; Matthay MA; Elson G; Dunn-Siegrist I
    Blood; 2004 Dec; 104(13):4071-9. PubMed ID: 15328161
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Curcumin Analog L48H37 Prevents Lipopolysaccharide-Induced TLR4 Signaling Pathway Activation and Sepsis via Targeting MD2.
    Wang Y; Shan X; Dai Y; Jiang L; Chen G; Zhang Y; Wang Z; Dong L; Wu J; Guo G; Liang G
    J Pharmacol Exp Ther; 2015 Jun; 353(3):539-50. PubMed ID: 25862641
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hyaluronan ameliorates LPS-induced acute lung injury in mice via Toll-like receptor (TLR) 4-dependent signaling pathways.
    Xu C; Chen G; Yang W; Xu Y; Xu Y; Huang X; Liu J; Feng Y; Xu Y; Liu B
    Int Immunopharmacol; 2015 Oct; 28(2):1050-8. PubMed ID: 26321117
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gene expressions of Toll-like receptor 2, but not Toll-like receptor 4, is induced by LPS and inflammatory cytokines in mouse macrophages.
    Matsuguchi T; Musikacharoen T; Ogawa T; Yoshikai Y
    J Immunol; 2000 Nov; 165(10):5767-72. PubMed ID: 11067935
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components.
    Dobrovolskaia MA; Medvedev AE; Thomas KE; Cuesta N; Toshchakov V; Ren T; Cody MJ; Michalek SM; Rice NR; Vogel SN
    J Immunol; 2003 Jan; 170(1):508-19. PubMed ID: 12496438
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Toll-like receptor 4 region Glu24-Lys47 is a site for MD-2 binding: importance of CYS29 and CYS40.
    Nishitani C; Mitsuzawa H; Sano H; Shimizu T; Matsushima N; Kuroki Y
    J Biol Chem; 2006 Dec; 281(50):38322-9. PubMed ID: 17056597
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The amino-terminal region of toll-like receptor 4 is essential for binding to MD-2 and receptor translocation to the cell surface.
    Fujimoto T; Yamazaki S; Eto-Kimura A; Takeshige K; Muta T
    J Biol Chem; 2004 Nov; 279(46):47431-7. PubMed ID: 15337750
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Toll-like receptor 4 deficiency increases resistance in sepsis-induced immune dysfunction.
    Cao C; Chai Y; Shou S; Wang J; Huang Y; Ma T
    Int Immunopharmacol; 2018 Jan; 54():169-176. PubMed ID: 29149705
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phosphoinositide 3 kinase mediates Toll-like receptor 4-induced activation of NF-kappa B in endothelial cells.
    Li X; Tupper JC; Bannerman DD; Winn RK; Rhodes CJ; Harlan JM
    Infect Immun; 2003 Aug; 71(8):4414-20. PubMed ID: 12874320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.